Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIBTEG: Fibrinogen in Ascending Aorta Surgery
NCT02299947Phase 4Terminated
- Start
- Aug 2014
- Primary completion
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hemorrhage comparing Haemocomplettan P with Placebo (2 arms). Primary endpoint: Number of transfused blood products. Started Aug 2014; status: terminated.
02
Drugs
Fibrinogen human
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT02299947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299947.